Latest News
WANDisco shares dive helter-skelter despite positive profit guidance
Shares in WANDisco gave up most of their strong gains from last week after the Big Data software specialist reported that revenues would be below the level expected though losses will be better than forecast.
US open: Stocks rally as Yellen's remarks suggest delay to rate hike
US stocks rallied as Federal Reserve Chair Janet Yellen flagged risks to the economy that could delay another increase in interest rates.
Fed chair Janet Yellen's speech - Analysts react
"Fed Chair Yellen's Testimony does not close the door to a March rate hike, given that the meeting is still more than a month away, but if the committee loses its nerve in the face of continued market volatility, no-one will be able to say they are surprised. [. ].
Domino's surges as Credit Suisse upgrades to 'outperform'
Domino’s Pizza Group shares surged after Credit Suisse upgraded the stock from ‘neutral’ to ‘outperform’ and added it to its Europe Small and Mid-Cap Focus List.
High Court rules against Drax and Infinis over green tax change
The UK High Court has ruled against London-listed power generation company Drax and renewable energy firm Infinis Energy, after they urged a review of the government’s decision to remove the climate change levy exemption.
FTSE 250 movers: Domino's leads index after upgrade
The FTSE 250 made some ground on Wednesday, with the second tier index up 252. 74 points (1. 65%) to 15,569. 67 by mid-afternoon.
Tighter financial conditions could weigh on economic outlook, Fed's Yellen says
Financial conditions in the US had become "less supportive" of economic growth and could weigh on the outlook should they persist, the chair of the US Federal Reserve, Janet Yellen, would tell Congressmen on Wednesday, according to the prepared remarks for her testimony.
4D Pharma expands research with Tuscana acquisition
4D Pharma expanded its research capabilities on Wednesday, acquiring university-based startup Tuscana Health Limited.
FTSE 100 movers: Housebuilders lead market higher
The FTSE 100 was set to turn things around on Wednesday, with the blue chip market up 48. 39 points (0. 86%) to 5,680. 58 by mid-afternoon.
Tullow Oil pegs back full year loss to $1bn
Tullow Oil has nearly halved its full year loss, however the company’s revenues for the year have dropped substantially.
Pinnacle Technology completes placing and open offer
Shareholders in Pinnacle Technology were proving their loyalty to the firm on Wednesday, with the company revealing its previously-announced open offer had been significantly oversubscribed.
EU and US reach agreement on derivatives
The European Union and the US have reached an agreement over derivatives that will see them adopt a “common approach” to clearing houses’ requirements, ending a long-standing dispute.
Tesco buys out Harris & Hoole coffee chain
Supermarket retailer Tesco has bought the remaining stake in coffee chain Harris & Hoole it did not already own.
Artilium strengthens call centre offer with Livecom acquisition
Artilium was strengthening its call centre offer on Wednesday, announcing the acquisition of both Livecom International BV and the Chinese joint venture of Livecom.
Eden Research bounces on first commercial order for Mevalone
Eden Research has received its first order for its Mevalone grape crop treatment from partner K&N Efthymiadis that will generate first revenue from the agreement.
Asahi offers to get SABmiller's beers in
Japan's Asahi has offered to pay €2. 55bn to acquire SABMiller's Peroni, Grolsch, and Meantime beer brands from Anheuser-Busch InBev to help the merger swerve competition concerns.
Pinewood still growing as it mulls possible sale
Pinewood Studios was holding steady on its growth trajectory in the second half of the year, as the company revealed it was undergoing a strategic review that could lead to its sale.
Real Good Food buys Devon-based Chantilly Patisserie
Real Good Food’s wholly-owned subsidiary Haydens Bakery has bought Chantilly Patisserie for £1. 75m, using existing cash resources.
US pre-open: Investors standing by for Yellen's testimony
US futures had risen in anticipation of Janet Yellen’s testimony to the House Financial Services Committee on Wednesday.
GW Pharma losses increase ahead of key epilepsy trial results
Cannabis-derived medicines specialist GW Pharmaceuticals posted a £17. 7m loss in the first quarter as it gears up to report data from four Phase 3 trials for its Epidiolex product.